Skip to main content
logo
Day One Biopharmaceuticals, Inc. (DAWN)
Apr 21, 2026 - DAWN was delisted (reason: acquired by Servier)
21.53
+0.04 (0.19%)
Inactive · Last trade price on Apr 22, 2026

DAWN Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
158.18158.18131.16---
Revenue Growth
20.60%20.60%----
Gross Profit
140.95140.97125.88---
Operating Income
-127.75-127.75-217.27-206.06-146.91-72.74
Net Income
-107.32-107.32-95.5-188.92-142.18-170.64
Earnings Per Share
-1.04-1.04-1.02-2.37-2.17-4.62
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
441.11441.11531.72366.35342.27284.31
Total Debt
2.792.792.60.410.810.22
Net Cash (Debt)
438.32438.32529.12365.94341.46284.09
Net Cash Growth
-17.16%-17.16%44.59%7.17%20.19%555.70%
Net Cash Per Share
4.254.255.684.595.227.69

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-103.76-103.76-78.11-146.85-109.87-48.54
Capital Expenditures
-0.32-0.32-2.17-0.22-0.03-
Free Cash Flow
-104.08-104.08-80.28-147.08-109.9-48.54
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
89.11%89.12%95.98%---
Operating Margin
-80.76%-80.76%-165.65%---
Pretax Margin
-69.10%-69.10%-67.36%---
Profit Margin
-67.85%-67.85%-72.81%---
FCF Margin
-65.80%-65.80%-61.21%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
14.066.079.77---